Stockreport

Amarin's Vascepa cuts occurrence of serious heart problems 30 percent: study [Reuters]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Amarin's Vascepa cuts occurrence of serious heart problems 30 percent: study | Reuters 3 Min Read (Reuters) - A high dose of Amarin Corp’s Omega-3 drug Vascepa significa [Read more]